Riggs Asset Managment Co. Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

Back to all holdings Add to watchlist

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$3,419
-1.5%
2210.0%0.00%0.0%
Q2 2023$3,472
-4.7%
2210.0%0.00%0.0%
Q1 2023$3,643
+5.7%
2210.0%0.00%0.0%
Q4 2022$3,448
+14.9%
2210.0%0.00%0.0%
Q3 2022$3,0000.0%2210.0%0.00%0.0%
Q2 2022$3,0000.0%2210.0%0.00%0.0%
Q1 2022$3,0000.0%2210.0%0.00%0.0%
Q4 2021$3,000
-25.0%
2210.0%0.00%0.0%
Q3 2021$4,0000.0%2210.0%0.00%0.0%
Q2 2021$4,0000.0%2210.0%0.00%0.0%
Q1 2021$4,0000.0%2210.0%0.00%0.0%
Q4 2020$4,000
+33.3%
2210.0%0.00%0.0%
Q3 2020$3,0000.0%2210.0%0.00%0.0%
Q2 2020$3,0000.0%2210.0%0.00%
-50.0%
Q1 2020$3,000
-25.0%
2210.0%0.00%0.0%
Q4 2019$4,000
+33.3%
2210.0%0.00%0.0%
Q3 2019$3,000
-25.0%
2210.0%0.00%0.0%
Q2 2019$4,0000.0%2210.0%0.00%
-33.3%
Q1 2019$4,000–221–0.00%–
 Download
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders